Abeona Therapeutics Files 8-K with Material Agreement

Ticker: ABEO · Form: 8-K · Filed: May 12, 2025 · CIK: 318306

Abeona Therapeutics Inc. 8-K Filing Summary
FieldDetail
CompanyAbeona Therapeutics Inc. (ABEO)
Form Type8-K
Filed DateMay 12, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, filing, corporate-action

TL;DR

ABEONA THERAPEUTICS INC. just signed a big deal, filing an 8-K. Could be huge.

AI Summary

On May 9, 2025, Abeona Therapeutics Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements and exhibits. Abeona Therapeutics Inc. is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing indicates a significant development for Abeona Therapeutics, likely involving a new contract or partnership that could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, making the company's future performance less certain until more details are disclosed.

Key Players & Entities

  • Abeona Therapeutics Inc. (company) — Registrant
  • May 9, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • 001-15771 (commission_file_number) — SEC File Number
  • 83-0221517 (ein) — I.R.S. Employer Identification No.

FAQ

What is the nature of the material definitive agreement entered into by Abeona Therapeutics Inc. on May 9, 2025?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

What other events are reported in this 8-K filing by Abeona Therapeutics Inc.?

Besides the material definitive agreement, the filing also lists 'Other Events' and 'Financial Statements and Exhibits' as reported items.

When is Abeona Therapeutics Inc.'s fiscal year end?

Abeona Therapeutics Inc.'s fiscal year ends on December 31.

What is the SEC file number for Abeona Therapeutics Inc.?

The SEC file number for Abeona Therapeutics Inc. is 001-15771.

In which state is Abeona Therapeutics Inc. incorporated?

Abeona Therapeutics Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding ABEONA THERAPEUTICS INC. (ABEO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.